Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06805461

PumaRx Registry Trial

Sponsor: RenovoRx

View on ClinicalTrials.gov

Summary

This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.

Official title: A Multi-Center, Observational, Post-Marketing, Registry Study Following Patients With Solid Tumors Treated With Therapeutic Agents Via Localized Intra-Arterial Delivery Using the RenovoCath® Catheter

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2025-08-01

Completion Date

2029-09-03

Last Updated

2026-03-30

Healthy Volunteers

No

Conditions

Interventions

DEVICE

RenovoCath®

Intra-arterial catheter delivery of chemotherapy agents for the collection of real-world data.

Locations (3)

Baptist Health South Florida

Coral Gables, Florida, United States

University of Pennsylvania Medical Center

Pittsburgh, Pennsylvania, United States

The University of Vermont Medical Center

Burlington, Vermont, United States